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For  the  control  of  cyathostomins  in horses,  the  macrocyclic  lactones  (MLs),  moxidectin  (MOX)  and
ivermectin  (IVM)  are  the  most  commonly  used  anthelmintics.  However,  reduced  activity,  observed  as
shortening  of the  egg  reappearance  period  (ERP)  has  been  described.  Shortening  of the  ERP may  be
caused  by a decreased  susceptibility  of  immature  worms  for MLs.  Alternatively,  immature  worms  may
develop faster  into  egg  producing  adults  as a result  of  repeated  ML treatments.  The  species  composition  of
the larval  cultures  obtained  shortly  after  ML  and  pyrantel  (PYR)  treatment  can  conﬁrm  the  hypothesis  of
decreased  ML susceptibility,  as  this  is  often  class-speciﬁc,  whereas  faster  development  would  also  occur
after treatment  with  anthelmintics  with  a different  mode  of  action.  From  3 farms  with  a  known  history
of  shortened  ERP, 8 horses  per  farm  were  selected  and  divided  into  2 groups.  The MOX-PYR-MOX  group
was  treated  twice  with  MOX  (day  0 and 126)  and  once  with  PYR  (day 84)  and  the IVM-PYR-IVM  group
was  treated  twice  with  IVM  (day 0 and  98)  and  once  with  PYR  (day 56).  Cultured  infective  larvae  (L3s)
were  counted  and  differentiated  with  the reverse  line  blot  on pooled  samples.  Per  cyathostomin  species,
the  number  of larvae  per  gram  was  calculated.  The  efﬁcacy  of  all ML  treatments  was  100%  and  a short-
ened  ERP  was  found  on  all 3 farms.  The  species  composition  of the  larval  cultures  after  ML  treatment  did
not  differ  signiﬁcantly  from  that after  PYR  treatment  in the  IVM-PYR-IVM  group,  but  it did  differ  in the
MOX-PYR-MOX  group.  The  larval  cultures  obtained  after  MOX  treatment  consisted  mostly  of  Cylicocyclus
nassatus,  while  after  PYR  treatment  Cylicostephanus  longibursatus  was  the  most  abundant  species.  In the
cultures  from  42  days  after  MOX  treatment  6  cyathostomin  species  from  3 genera  were  found  on  the
farm with  the  lowest  activity  (farm 1),  while  on  the farm  with  the  highest  activity (farm  3)  only  3  species
from  one  genus  were  found  in  the  same  number  of examined  L3s.  The  high  numbers  of  L3s  of  Cylicocyclus
species  42 days  after  MOX  treatment  and  the  low  numbers  42  days  after  PYR  treatment  can  be explained
by  reduced  susceptibility  of the  immature  worms  to  MOX,  but not  by  a faster  development.  In  conclusion,
shortening  of  the  ERP  following  MOX  treatment  is  most  likely  a process  in  which  an  increasing  number
of  immature  worms  from  an  increasing  number  of species  is  becoming  less  susceptible  to the  active
compound.
©  2016  The  Author(s).  Published  by Elsevier  B.V. This  is  an open  access  article  under  the CC  BY  license. Introduction
Cyathostomins are the most prevalent nematodes in equids
orldwide. Macrocyclic lactones (MLs) are currently the most
sed anthelmintics, of which ivermectin (IVM) and moxidectin
∗ Corresponding author.
E-mail address: f.n.j.kooyman@uu.nl (F.N.J. Kooyman).
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(MOX) are registered for the control of cyathostomins in horses
(Reinemeyer and Rohrbach, 1990; Nielsen et al., 2014).
The egg reappearance period (ERP) is the time between treat-
ment and the reappearance of eggs in the feces. The ERP for IVM
and MOX  at the time of introduction has been reported to be 8–9
weeks (Borgsteede et al., 1993; Parry et al., 1993; Boersema et al.,
1996, 1998) and 12–25 weeks (Demeulenaere et al., 1997; DiPietro
et al., 1997; Boersema et al., 1998), respectively. However, world-
wide reduced ERP has been reported both for IVM and MOX  (von
 under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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amson-Himmelstjerna et al., 2007; Lyons et al., 2011b; Molento
t al., 2012; Geurden et al., 2014).
Several mechanisms can explain the shortening of the ERP. After
L treatment, the ERP is often shorter than the shortest pre-patent
eriod (PPP) of 57 days for cyathostomins (Lyons et al., 2011a) and
hortening of the ERP has also been observed in housed horses
van Doorn et al., 2014). This indicates that larvae already present
n the host at the time of treatment must be responsible for the
hortening of the ERP. Therefore, a reduced ERP is regarded as
n early sign of development of resistance (Lyons et al., 2009).
 shift within the cyathostomin population towards species with
 shorter development time is not a likely cause, as horses with
nd without a shortened ERP showed a similar species composi-
ion before treatment (van Doorn et al., 2014). Furthermore, 20
ears of ML  treatment did not result in a change in the cyathos-
omin species composition within the same herds (Chapman et al.,
002). Therefore, shortening of the ERP is most likely caused by
ecreased susceptibility of immature stages to MLs  or by a faster
ace of development of immature stages into egg producing adults.
n a critical test described by Lyons et al. (2010), the efﬁcacy of MOX
gainst luminal larval stages in one horse was only 82%, while the
fﬁcacy against adult cyathostomins was still 100% in the same
orse. Critical tests performed by the same group demonstrated
 effectivity of IVM against L4s of 36–80% (Lyons et al., 2009) and
 years later the effectivity against L4s has dropped to only 0–16%
Lyons and Tolliver, 2013). The effectivity against adults was  in both
ases higher than 99%. The authors suggested that this was caused
y reduced efﬁcacy of MLs  against the immature luminal stages,
ut they could not exclude the possibility of a fast development
f mucosal stages into luminal stages in the 6 days between ML
reatment and necropsy.
Experimentally, it may  be possible to distinguish faster develop-
ent from decreased susceptibility for MLs  because a faster pace of
evelopment from L4 into egg laying adult should also occur after
reatment with an anthelmintic outside the ML  group e.g. pyrantel
PYR). A faster development can be advantageous for the parasite. It
ncreases the chance to reproduce in between 2 subsequent treat-
ents. Plasticity of the development time in nematodes has been
emonstrated before, for example in Anguillicola crassus,  a para-
itic nematode of the Japanese and European eel (Weclawski et al.,
013).
A  shortened ERP does not necessarily involve all present
yathostomin species. One species may  be more prone to develop
esistance or may  have a higher level of plasticity than another.
lthough differentiation of the eggs or cultured L3s by morpholog-
cal means is not possible, they can be differentiated by molecular
ethods (Traversa et al., 2007; van Doorn et al., 2010, 2014;
wiklinski et al., 2012). These studies used the reverse line blot
RLB), a method based on the hybridization of species speciﬁc
robes with an ampliﬁed fragment of the intergenic spacer (IGS)
egion. Individual L3s can be differentiated into 21 of the most
ommon cyathostomin species (Cwiklinski et al., 2012). Recently,
 RLB on pooled L3s was described for the differentiation of larval
ultures allowing an estimation of the larvae per gram (LPG) per
yathostomin species (Kooyman et al., 2016).
The aims of this study were to determine which species are
nvolved in the shortening of the ERP and to determine the cause
f shortening of the ERP: reduced susceptibility to MLs  or a faster
evelopment of the species involved.
. Material and methods
.1. Farms and horsesThis study was designed as a ﬁeld study in the Netherlands
ith horses naturally infected with cyathostomins and lasted from
ebruary to September 2013. Three farms were selected basedrasitology 227 (2016) 77–84
on the presence of a shortened ERP in 2012 after ML  treatment
(Geurden et al., 2014). Farms NEO1, NEO2 and NEO3 from that study
correspond to farm 1–3, respectively in the present study. The 3
farms practiced regular deworming (at least twice a year). On each
farm, 8 horses (2–3 years old) with ≥150 eggs per gram (EPG) were
randomly allocated to one of the two treatment groups. The IVM-
PYR-IVM group was  treated with IVM (Eqvalan® oral paste, Merial
at 0.2 mg/kg bodyweight) at day 0 and day 98 and in between (day
56) with PYR (Strongid-P® paste, Pﬁzer at 19 mg/kg bodyweight).
The MOX-PYR-MOX group was  treated with MOX  (Equest® oral
gel, Pﬁzer at 0.4 mg/kg bodyweight) at day 0 and day 126 and in
between (day 84) with PYR. The PYR treatments in between the
ML  treatments were timed according to the regular ERP of the
respective ML  products. Before each treatment the bodyweight was
estimated with a girth tape. In order to minimize under-dosing,
the dose was  based on 110% of the estimated bodyweight. Fecal
samples were collected at day −5 to day −2 from both groups and
at day 14, 42, 56, 70, 98, 112, 140, 154 from the IVM-PYR-IVM
group and at day 14, 42, 56, 84, 98, 126, 140, 168, 182 and 210
from the MOX-PYR-MOX group. All fecal samples were used for
egg counts and larval cultures and all larval cultures were counted
and differentiated.
2.2. Egg counts and larval cultures
Egg counts and culturing of L3s were performed as described
(van Doorn et al., 2014) with a detection limit of 25 EPG and 0.4
larvae per g (LPG). The recovery of the L3s (100% × LPG/EPG) was
calculated for all samples with positive EPG and positive LPG. The
mean recovery of a group is the mean of the recoveries of all indi-
vidual samples from that group.
2.3. Drugs activity and egg reappearance period (ERP)
There are no formal guidelines for obtaining one clear estimate
for the activity of anthelmintics by fecal egg count reduction test
(FECRT) in horses (Vidyashankar et al., 2012). For the present study
the activity of a drug for the herd was determined by taking the
mean of the arcsine transformed activity of the individual horses
(Pook et al., 2002; Relf et al., 2014). For small groups of horses, it is
an advantage that no control group is needed when using the indi-
vidual activity. The activity at day 14 after treatment is deﬁned as
the efﬁcacy (EFF) and determines whether there is resistance or not.
A mean EFF–2 SE ≤95% at day 14 after ML  treatment was deﬁned as
resistance. ERP is deﬁned here as the period between treatment and
the moment that the EPG increased to ≥10% of the pre-treatment
EPG (Borgsteede et al., 1993; von Samson-Himmelstjerna et al.,
2007; van Doorn et al., 2014).
2.4. Polymerase chain reaction (PCR) and reverse line blot (RLB)
PCR and RLB on pooled L3s as well as the transformation of RLB
score into a frequency and a LPG per cyathostomin species was
performed as described (Kooyman et al., 2016). In brief, for the
differentiation of one culture, 4 pools with 10 L3s each were sub-
jected to PCR and RLB with 19 species speciﬁc probes allowing the
differentiation into 17 cyathostomin species belonging to 7 gen-
era. For convenience, the genera were abbreviated to 3 or 4 letters,
instead of the ofﬁcial 1 letter. Differentiated species were: Cylico-
cyclus (Cyc. ashworthi, Cyc. insigne, Cyc. nassatus, Cyc. leptostomum),
Cylicostephanus (Cys. calicatus, Cys. goldi, Cys. longibursatus, Cys.
minutus var. A, Cys. minutus var. B), Cyathostomum (Cya. catinatum,
Cya. pateratum, Cya. tetracanthum), Coronocyclus (Cor. coronatus,
Cor. labiatus, Cor. labratus), Cylicodonthophorus (Cyd. bicoronatus)
Parapoteriostomum (Para. mettami) and Poteriostomum (Pot. impar-
identatum). The presence of a species within a pool was determined
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y hybridization of the homologues probe. For every pool in which
 species was identiﬁed, the species scored 1 point. The scores of a
pecies (0–3 or 4 points) is related to the frequency in which that
pecies was present in the larval culture (Kooyman et al., 2016).
cores for a species of 0–3 or 4 points corresponds to the median
requency for that species of 0.014, 0.04, 0.08, 0.16 or 0.59, respec-
ively. The frequency multiplied with the LPG obtained from culture
ounts results in a semi-quantitative estimation of the LPG per
pecies.
.5. Statistical analysis
Linear correlation between EPG and LPG was measured with
earson’s correlation coefﬁcient (r). The effect of the ML  and PYR
reatments on the LPGs per species was tested using mixed-effects
egative binomial regression models, which are suited to model
arasitological count data like LPGs (Wilson and Grenfell, 1997;
tancampiano et al., 2010) and have been used previously to model
imilar dependent variables (Lello et al., 2004; Stancampiano et al.,
010; Mughini Gras et al., 2011). In these models, a random effect
as included to account for clustering of observations at the level
f individual horse, whereas two categorical variables, one deﬁning
he farm of origin and the other one deﬁning the days post treat-
ent, were included as ﬁxed effects. The same modelling approach
as also used for comparing the LPGs of different species with each (B) treatment group from farm 1 (blue diamonds), farm 2 (red squares) and farm 3
 indicated days. (For interpretation of the references to colour in this ﬁgure legend,
other. Results were expressed as rate ratios (RR) and 95% conﬁ-
dence intervals (95%CI). Statistical analysis was performed using
STATA v.13 (StataCorp, College Station, USA).
3. Results
3.1. Egg counts and activity
One horse from the IVM-PYR-IVM group from farm 2 was
removed from the experiment for reasons not related with para-
sites and was not replaced. No data were generated from this horse.
The EPGs from the individual horses are shown in the Supplemen-
tary data (Table S1) and the mean EPGs per farm per treatment
group are shown in Fig. 1. The activities of the MLs  and ERPs are
given in Table 1. The activity of all ML  treatments 14 days after
treatment (efﬁcacy) was 100%. The ERP after all ML  treatments was
shortened to between 14 and 42 days in both groups from farms 1
and 2 and after the 2nd IVM treatment on farm 3. The ERP on farm
3 after the 1 st MOX  and 1st IVM treatments was not shortened and
after the 2nd MOX  treatment the ERP was  shortened to between
42 and 56 days. The mean efﬁcacy of PYR at day 14 ranged from
98 to 100% in all groups. The decrease in egg counts in the MOX-
PYR-MOX group of farm 2 at day 56 after the 1st MOX  treatment
was caused by the missing value of horse 2 and an unexplained
80 F.N.J. Kooyman et al. / Veterinary Parasitology 227 (2016) 77–84
Table 1
Mean activities of the 1st and 2nd ML  (IVM or MOX) and PYR treatments at day 14, 42 and 56 after treatment. For the MLs  only the days before the regular ERP are given
(before  day 56 for IVM and before day 84 for MOX). Activities ≤0.90 indicate shortening of the ERP and are given in bold.
Farm Group 1st ML  PYR 2nd ML
D14 D42 D56 D14 D42 D14 D42 D56
1 IVM-PYR-IVM 1.00 0.89 1.00 0.10 1.00 0.48
MOX-PYR-MOX 1.00 0.51 0.14 1.00 0.19 1.00 0.25 0.00
2  IVM-PYR-IVM 1.00 0.73 0.98 0.21 1.00 0.67
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ecrease in egg count of the horse with highest egg counts 14 days
arlier (horse 5).
.2. Larval cultures
The mean larval recovery was 67%. The LPG correlates signif-
cantly with the EPG (r2 = 0.635, p < 0.01) and was similar for all
arms (Fig. 2) and treatment groups (not shown).
.3. RLB on pooled samples
.3.1. Species composition of larval cultures and LPG per species
The LPGs per species and the summation of the LPGs per species
re given in Table S2 of the Supplementary data, together with the
otal LPGs resulting from the larval counts. Because Cyc. leptosto-
um  and Cyc. ashworthi were both recognized by the LEP2 probe,
he scores for the Cyc. ashworthi speciﬁc probe (ASH2) were not
ncluded in the summation (Kooyman et al., 2016). The LPGs for
he 6 most abundant species or combination of species (Cyc. nassa-
us, Cyc. leptostomum/ashworthi, Cyc. ashworthi, Cys. longibursatus,
ya. catinatum and Cya. pateratum)  representing the 3 most abun-
ant genera (Cylicocyclus, Cylicostephanus and Cyathostomum)  are
iven in Fig. 3.
The LPGs for these 6 species within the IVM-PYR-IVM group all
aried in a similar way in response to the treatments, although the
evels of the LPGs were different for the different species (Fig. 3,
eft column). The Cylicocyclus species were the most abundant, fol-
owed by Cylicostephanus and Cyathostomum species. The species
omposition 42 days after the IVM treatments (day 42 and day 140)
as not signiﬁcantly different from the one 42 days after PYR treat-
ent (day 98). On farm 3, the LPGs for the individual species were
ower after the treatments than on the 2 other farms, corresponding
o the less shortened ERP at that farm (Table 1).
In cultures from the MOX-PYR-MOX groups (Fig. 3, right
olumn), there was a change in the species composition after treat-
ent. The LPGs of species from the genus Cylicocyclus, especially
yc. nassatus, were high at 42 days after the 1st and 2nd MOX  treat-
ent (day 42 and day 168, respectively), but much lower at 42 days
fter PYR treatment (day 126). Farm 1 with the lowest activity of
OX showed at 42 days after MOX  treatment the highest LPGs and
he largest variety of cyathostomin species (Cyc. insigne, Cyc. nassa-
us, Cyc. ashworthi,  Cyc. leptostomum, Cys. goldi, Cys. longibursatus
nd Cor. coronatus), while at the same day from the farm with
he highest activity (farm 3) only low LPGs of Cyc. nassatus, Cys.
eptostomum and Cys. insigne were found in the same number of
ifferentiated L3s. The Cys. longibursatus LPGs showed a completely
ifferent pattern than the LPGs of the Cylicocyclus species, being
bsent or low at 42 days after MOX  treatments and high after PYR
reatment in all 3 farms. Therefore, the LPGs of Cyc. nassatus and Cys.
ongibursatus at 42 days after the treatments were further analyzed
s a measure for the differential effect of the PYR and MOX  treat-
ent on the different species. While adjusting for the effect of the
arm of origin and accounting for the individual horse variability,0.98 0.47 1.00 0.56 0.24
1.00 0.13 1.00 0.27
1.00 0.33 1.00 1.00 0.15
Cyc. nassatus LPGs at 42 days after the 1 st (RR 3.95, 95%CI 2.44–6.43,
p < 0.001) and 2nd (RR 4.44, 95%CI 2.47–7.98, p < 0.001) MOX  treat-
ments were signiﬁcantly higher than those at 42 days after the
PYR treatment. In contrast, no signiﬁcant differences existed in the
Cyc. nassatus LPGs between the 1 st and 2nd post MOX  treatments
(p = 0.665). The Cyc. nassatus LPGs 42 days after the 1 st and 2nd
MOX  treatments were the highest (mean LPG 124 and 176, respec-
tively) on the farm with the lowest activity (farm 1) and the lowest
(mean LPG 47 and 0.5 LPG) on the farm with the highest activity
(farm 3). Regarding Cys. longibursatus, its LPGs at 42 days after the
1 st (RR 0.12, 95%CI 0.06–0.26, p < 0.001) and 2nd (RR 0.15, 95%CI
0.07–0.32, p < 0.001) MOX  treatments were signiﬁcantly lower than
those at 42 days after the PYR treatment, with no signiﬁcant dif-
ferences in Cys. longibursatus LPGs between the 1 st and 2nd MOX
treatment (p = 0.628).
When comparing the LPGs of Cyc. nassatus and Cys. longibur-
satus, it was found that at the beginning of the experiment
(pre-treatment), the LPGs did not differ signiﬁcantly from one
another, but after the treatments they did. The Cyc. nassatus LPGs
42 days after the 1 st (RR 5.47, 95%CI 2.64–11.37, p < 0.001) and 2nd
(RR 4.95, 95%CI 2.34–10.49, p < 0.001) MOX  treatments were sig-
niﬁcantly higher than those of Cys. longibursatus, whereas after the
PYR treatment, the Cys. longibursatus LPGs were signiﬁcantly higher
than those of Cyc. nassatus (RR 2.65, 95%CI 1.42–4.95, p = 0.002). The
species from the genus Cyathostomum had low LPGs on all farms
before treatment and remained low throughout the experiment.
3.3.2. The reliability of the differentiation by RLB on pooled
samples
The LPG per treatment group obtained by larval counts and by
summation of the LPGs per cyathostomin species were similar and
gave a similar pattern in time for all 3 farms (Supplementary data,
Fig. S1).
4. Discussion
The cultured L3s obtained after ML  and after PYR treatment
from farms with a shortened ERP were counted and differentiated
with RLB on pooled samples. Differentiation of the excreted eggs
and/or cultured L3s obtained early after the different treatments
can provide more insight into the potential causes of a shorter ERP.
Because egg and larval counts correlated linearly it was  decided
to differentiate the L3s, because they can be harvested and stored
more easily than eggs. The species composition of the cultured L3s
was estimated with RLB on pooled samples. Cwiklinski et al. (2012)
described the differentiation of 21 cyathostomin species with RLB,
but for 3 of those species the speciﬁcity of the probes was not veri-
ﬁed with homologous differentiated adults. Kooyman et al. (2016)
demonstrated that of the 18 remaining species the probe for Cyc.
radiatus could not be used in RLB on pooled samples because of
putative cross-hybridization. Therefore, in the present study probes
for 17 species were used and only of the species Cyd. bicorona-
tus, Pot. imparidentatum, Cya. tetracanthum and Cor. labratus no L3s
F.N.J. Kooyman et al. / Veterinary Parasitology 227 (2016) 77–84 81
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ere found. The LPGs obtained directly from culture larval counts
ere similar to the summation of all LPGs per species obtained from
he pooled samples in the RLB. This implies that the latter provides
eliable estimations of the LPGs per species.
On all 3 farms, the LPG per cyathostomin species and the species
omposition of the larval culture changed in response to the dif-
erent treatments in the MOX-PYR-MOX groups, but not in the
VM-PYR-IVM group. At introduction of the drug the ERP for MOX
as much longer than for IVM, most likely because of the larvi-
idal effect of MOX. However, the activity of the IVM and MOX
reatments at the same day after treatment were in this study com-
arable. Therefore, the relative shortening of the ERP after MOX
reatments was more pronounced than after IVM treatments. This
ay  explain the rather small differences in species composition
efore and after IVM treatment, while there were larger differences
efore and after MOX  treatment. It is expected that more Cylico-
yclus will be found when the sampling is done earlier after IVM
reatment. This is in agreement with van Doorn et al. (2014). They
ifferentiated L3s obtained earlier after IVM treatment (day 28 and
5) and relatively more Cylicocyclus species were found on those
ays than on days 42 or 56 after treatment. An important difference
etween the present study and van Doorn et al. (2014) was  the use
f 2 the same ML  treatments with a PYR treatment in between in the
resent study. That offered the opportunity to compare the species
omposition of the cultured L3s obtained 42 days after ML  treat-
ent with those obtained from the same horse 42 days after PYR
reatment. Furthermore, the inﬂuence of the season can be evalu-
ted because the 2 ML  treatments were separated in time (98 days
or IVM and 126 days for MOX  treatments) with the PYR treatment
n between. The EPGs and the species composition of the L3 cultures
btained after 1st and 2nd ML  treatment were comparable. This
ndicates that there was no clear seasonal effect. More importantly,
ossible differences in the effect of the PYR and ML treatments can
herefore not be attributed to seasonal effects.
The species composition of the larval cultures obtained 42 days
fter MOX  and PYR treatment were compared. In comparison to Cyc.ples with a positive EPG and positive LPG from farm 1 (blue diamonds), farm 2 (red
ly signiﬁcant (p < 0.01). (For interpretation of the references to colour in this ﬁgure
nassatus, Cys. longibursatus was  more abundant after PYR than after
MOX  treatment. Cys. longibursatus is a much smaller worm than Cyc.
nassatus with a shorter PPP, 57 versus 71 days (Lyons et al., 2011a),
and it is therefore likely that the development time from mucosal
stage to adult worm is also shorter in Cys. longibursatus than in Cyc.
nassatus. MOX  has activity against mucosal stages, whereas PYR
activity is restricted to adults and to a lesser extent other luminal
stages (Chapman et al., 1996; Lind et al., 2003). This can explain why
the Cys. longibursatus LPG was higher at 42 days after PYR treatment
than after MOX  treatment and also that Cys. longibursatus LPG was
higher than Cyc. nassatus LPGs at day 42 after PYR. Resistance of Cys.
longibursatus against PYR could also have explained the high LPGs
of this worm after PYR, but seems unlikely because of the very high
efﬁcacy (99%) of PYR in the present study, similar to that found in
previous studies (Boersema et al., 1991; Eysker et al., 1991; Lyons,
1974). And even when there is PYR resistance in Cys. longibursatus,
it cannot explain the low Cyc. nassatus LPG after PYR treatment.
In contrast, the Cylicocyclus species, especially Cyc. nassatus,
were more abundant after MOX  treatment than after PYR treat-
ment. This can only be explained by the presence of worms that
developed at a faster pace from L4 to adult or by worms less sus-
ceptible for MOX. A faster pace of development will be independent
of the anthelmintic used and therefore the same should have been
seen after PYR treatment. However, higher Cylicocyclus LPGs were
found at 42 days after MOX  than at the same day after PYR treat-
ment. This suggests that the shortening of the ERP is not caused by
a faster development of Cylicocyclus species. Furthermore, despite
the fact that the Cylicocyclus LPGs on farm 1 and farm 3 were sim-
ilar at pre-treatment, they were higher on farm 1, with the lowest
MOX  activity than on farm 3, with the highest MOX  activity, after
both MOX  treatments. If this would have been caused by a faster
development, the same was expected after PYR treatment. How-
ever, we  found similar Cylicocyclus LPGs for farm 1 and 3 after PYR
treatment. Therefore, it was concluded that shortening of the ERP
after MOX  treatment is most probably caused by reduced suscep-
tibility of the (mainly Cylicocyclus) immature worms and not by
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Fig. 3. The mean larvae per gram (LPG) of the 6 most abundant species (Cyc. nassatus, Cyc. ashworthi, Cyc. leptostomum, Cys. longibursatus, Cya. catinatum and Cya. pateratum)
from  the 3 most abundant genera (Cylicocyclus, Cylicostephanus and Cyathostomum) are given for all sample days for farm 1 (top row), farm 2 (middle row) and farm 3 (bottom
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aow).  The IVM-PYR-IVM groups are given in the left column, the MOX-PYR-MOX gr
arrowheads) were given on the indicated days.
 faster development from immature to adult. Cross-resistance is
nlikely to be at play here, because the species that returned early
fter MOX  treatment were different from those that returned early
fter PYR treatment.
The fact that reduced susceptibility and not faster develop-
ent is the most likely cause for ERP shortening has most likely
mplications for the possibility to reverse development of MOX
esistance, or more precisely the restoration of the original ERP.
t is to be expected that in case of faster development both slow
nd faster developing immature worms will be killed by MOX, as
hey will have similar susceptibility to MOX. Alternatively, in case of
educed larval susceptibility to MOX, MOX  will predominantly kill
he susceptible individuals. At the time MOX  was ﬁrst marketed, the
ajority of larvae was still developing at 84 days post MOX treat-
ent when the ﬁrst eggs re-appeared. Consequently, the majority
f larvae with a regular slow rate of development or with a regular
usceptibility will not reach the adult stage at day 84 after MOX.
his implies that a PYR treatment given at day 84 after MOX, will
redominantly kill individuals with either a faster development or
 reduced MOX  susceptibility responsible for the shortened ERP.are given in the right column. The ML  treatments (arrows) and the PYR treatments
Therefore, the net result (combined effect of MOX  followed by PYR
at day 84) will have little effect on restoring a shortened ERP in case
of reduced MOX  susceptibility, because MOX  will kill the suscep-
tible individuals whereas PYR, given 84 days later, will mostly kill
the resistant individuals responsible for the shortened ERP. There-
fore, the ratio between susceptible and less susceptible individuals
may  be expected to remain largely the same. In case shortened ERP
is caused by a faster development, the net result would have been
selection against individuals with a faster development, because
MOX will kill both slow and fast developing individuals, while
PYR would predominantly kill the fast developing worms. Conse-
quently, the ratio between slow and fast developing individuals
would change in favor of the slower developing individuals. This
implies that in this case it might be more feasible to reverse a short-
ened ERP back to the original ERP with a PYR treatment 84 days after
a MOX  treatment compared to the situation of reduced larval sus-
ceptibility to MOX. If there would be cross-resistance between MOX
and PYR, the different effects resulting from reduced susceptibility
versus faster development would even be more pronounced, as in
such a case PYR would be less able to kill MOX  resistant individuals.
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LPGs at day 42 after MOX  treatment were low on the farm with
he least reduced ERP (farm 3), whereas LPGs were high on the farm
ith the strongest reduced ERP (farm 1). The species composition
lso differed between these 2 farms; on farm 3 only Cylicocyclus
pecies (mainly Cyc. nassatus) were found in cultures after both
OX  treatments, while on farm 1, other Cylicocyclus species were
lso abundant as well as that species from other genera were found
Cylicostephanus, Cyathostomum and Coronocyclus).  This suggests
hat in the early stages of shortening of ERP Cylicocyclus species
mainly Cyc. nassatus) dominate, or in other words, appear to be the
rst species in which a lesser susceptibility becomes apparent. In
ater stages, when shortening of ERP has progressed, species com-
osition becomes more diverse as other species also become less
usceptible. A similar pattern was found by van Doorn et al. (2014).
anever et al. (2013) and Traversa et al. (2009) already demon-
trated egg reappearance at 14 days after ML treatment. To our
nowledge, nothing was  reported about the species composition
f these early excreted eggs.
In conclusion, this study provides evidence that a shortening
f the ERP is a process in which an increasing number of imma-
ure worms from an increasing number of cyathostomin species
re becoming less susceptible to MOX  and possibly IVM, although
his was not clear in the present study. Monitoring shortening of
he ERP as an early sign of resistance development can help in eval-
ating old and new treatment strategies in order to be able to use
he still effective MLs  for an extended period of time.
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